Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus clarithromycin for chronic sinusitis
IRCT20201209049661N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in rhinosinusitis comparing Azithromycin with Clarithromycin (2 arms). Primary endpoints: Sinusitis symptoms and Lund-Mackay score. Started Apr 2018; status: completed.
02
Drugs
azithromycinclarithromycin
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on IRCT20201209049661N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201209049661N1.